AIRLINK 211.85 Increased By ▲ 2.30 (1.1%)
BOP 10.55 Increased By ▲ 0.09 (0.86%)
CNERGY 7.38 Increased By ▲ 0.03 (0.41%)
FCCL 34.59 Increased By ▲ 0.20 (0.58%)
FFL 18.16 Increased By ▲ 0.11 (0.61%)
FLYNG 23.35 Increased By ▲ 0.43 (1.88%)
HUBC 131.81 Decreased By ▼ -0.68 (-0.51%)
HUMNL 14.28 Increased By ▲ 0.14 (0.99%)
KEL 5.11 Increased By ▲ 0.08 (1.59%)
KOSM 7.20 Increased By ▲ 0.13 (1.84%)
MLCF 45.26 Increased By ▲ 0.06 (0.13%)
OGDC 220.90 Increased By ▲ 2.52 (1.15%)
PACE 7.75 Increased By ▲ 0.17 (2.24%)
PAEL 42.46 Increased By ▲ 0.76 (1.82%)
PIAHCLA 17.54 Increased By ▲ 0.24 (1.39%)
PIBTL 8.75 Increased By ▲ 0.20 (2.34%)
POWERPS 12.50 No Change ▼ 0.00 (0%)
PPL 191.00 Increased By ▲ 1.97 (1.04%)
PRL 42.70 Increased By ▲ 0.37 (0.87%)
PTC 25.70 Increased By ▲ 0.53 (2.11%)
SEARL 104.50 Increased By ▲ 0.54 (0.52%)
SILK 1.03 No Change ▼ 0.00 (0%)
SSGC 41.15 Increased By ▲ 1.91 (4.87%)
SYM 19.45 Increased By ▲ 0.29 (1.51%)
TELE 9.44 Increased By ▲ 0.20 (2.16%)
TPLP 13.00 Decreased By ▼ -0.10 (-0.76%)
TRG 70.60 Increased By ▲ 1.42 (2.05%)
WAVESAPP 10.76 Increased By ▲ 0.04 (0.37%)
WTL 1.72 Increased By ▲ 0.01 (0.58%)
YOUW 4.18 Increased By ▲ 0.04 (0.97%)
BR100 12,229 Increased By 150 (1.24%)
BR30 37,008 Increased By 405.3 (1.11%)
KSE100 117,323 Increased By 1269.9 (1.09%)
KSE30 37,003 Increased By 425.8 (1.16%)

Pakistan fast bowler, Shoaib Akhtar denied on Monday knowingly taking any performance-enhancing drugs after testing positive for the anabolic steroid nandrolone. "I want to assure everyone that I am innocent of doing anything I shouldn't have," Akhtar told the bigstarcricket.com Web site.
"All I can say at this stage is that I have not knowingly taken any performance-enhancing drugs and would never cheat my team mates or opponents in this way."
Akhtar said he had always played the game fair and given 100 percent and never felt the need to take any drugs to help his bowling. "I am gutted to be missing the Champions Trophy and I will return to Pakistan to see what has happened and what needs to be done," he said.

Copyright Reuters, 2006

Comments

Comments are closed.